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Abstract
Background: To study the expression of Plexin-B1, Glycodelin, and MMP7 during the menstrual
cycle in the endometrium and in the fallopian tube.
Methods: The research included women undergoing hysterectomy, tubal sterilization or salpingo-
oophoerectomy. Total RNA from endometrial and fallopian tube tissues was extracted using a total
RNA isolation kit. Semi-quantitative RT-PCR was performed to examine mRNA relative
expression.
Results:  Plexin-B1 expression in the endometrium was significantly higher on days 19 - 23
compared to days 12 - 14 (1.166 +/- 0.42 versus 0.523 +/- 0.299), P < 0.005. In the fallopian tube
the level of plexin-B1 did not change significantly throughout the menstrual cycle. Glycodelin
expression was significantly higher on days 19 - 23 compared with days 12-14, both in the
endometrium (0.819 +/- 0.564 versus 0.072 +/- 0.343, P < 0.05) and the fallopian tube (0.796 +/-
0.196 versus 0.329 +/- 0.398, P < 0.05). Although the level of MMP7 secretion was the highest in
the secretory phase the difference from the proliferative phase did not reach statistical significance,
neither in the endometrium nor in the fallopian tube. This could result from a lack of power.
Conclusions: In the endometrium, both Glycodelin and Plexin-B1 are exhibiting a cyclic pattern
suggesting a possible steroid regulation and a role in endometrial receptivity.
Background
Implantation in humans involves complex interactions
between the embryo and the maternal endometrium.
Endometrial receptivity is suggested to be a property of
the endometrial epithelial cells. The molecular mecha-
nisms by which the surface of the human endometrium
acquires morphological changes, leading to receptive fea-
tures, are still unclear. Cytokines, growth factors, hor-
mones, extracellular matrix proteins and enzymes,
angiogenic factors, cell-cell adhesion molecules and
receptors are all involved in this complex process [1-5].
The endometrium is receptive to embryonic implantation
during a defined window that is temporally and spatially
restricted [1-5]. Coordinated effects of ovarian progester-
one and estrogen play critical roles in establishing uterine
receptivity for implantation [1-5]
In order to define the proteins involved in the implanta-
tion processes, gene expression in the endometrium was
investigated during the menstrual cycle [6-8]. The expres-
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sion of several proteins in the fallopian tube, with com-
parison to the endometrium, was also described [9-11].
In the present study, we investigated the expression in the
endometrium and the fallopian tube of three genes, pro-
posed to be involved in endometrial receptivity and
maternal-trophoblastic interactions.
Glycodelin is a member of the lipocalin family of pro-
teins, is synthesized in the endometrium in response to
progesterone and relaxin and has immunosuppressive
properties and is suggested as a potential receptivity
marker [12].
Matrix metalloproteinase 7 (MMP7) is secreted mostly
from the endometrial epithelium cells where attachment
occurs and is suggested to be important in the implanta-
tion process [13].
Plexin B1 is a member of the plexin receptor family for
secreted and membrane-bound semaphorines guiding
cell migration and exon extension [14]. Plexin B1 is
known to be involved in angiogenesis, epithelial morpho-
genesis and invasive growth in epithelial cells [15].
Recently, Plexin B1 was found to be expressed in the
mouse ovary and to have a role in follicular growth and
steroidogenesis [16] and in endometrial receptivity of
human endometrial cell lines [17].
Methods
Patient selection
The research included women undergoing hysterectomy,
tubal sterilization or salpingo-oophoerectomy for reasons
other than malignant or premalignant disease. All
patients undergoing adnexal surgery agreed to endome-
trial sampling (pipelle) during the procedure. Tubal steri-
lization was performed by cutting the mid part (ampula)
of the tubes. Sixteen women underwent hysterectomy:
eight due to myomatous uterus, four due to metrorrhagia,
three due to uterine prolapse and one due to chronic pel-
vic pain. An additional four underwent tubal sterilization
and two had a salpingo-oophorectomy due to an ovarian
cyst. Patients with endometriosis, inflammatory or infec-
tious disease were excluded. From each participant two
samples were taken, one from the endometrium and the
second from the fallopian tube.
All included women reported having regular menstrual
cycles (28-35 days) and were not pregnant at the time of
surgery. All participants were divided according to their
phase in the menstrual cycle. Day of menstrual cycle was
calculated from the first day of the last menstruation prior
to the operation day. Five various phases of the menstrual
cycle were determined: early proliferative (day 5-7), mid-
proliferative (day 8-11), late proliferative (day 12-14),
early secretory (day 15-18) and mid-secretory (day 19-
23). Dating of the menstrual cycle phase was confirmed
with histology and hormonal profile.
The women's age ranged from 30 to 50 years with mean
age of 41.13 ± 5.43 years. Blood samples for hormonal
profile, including LH, FSH, Estradiol and Progesterone
levels were drawn 2-24 hours before surgery.
In the operation room a small sample of endometrium
and from the tubal epithelium was drawn for the research
frozen at -80°C until use. The remaining tissue was sent
for pathological examination and checked for occult
malignancy, signs of inflammation and endometrial dat-
ing. If a mismatch was found between menstrual cycle
day, histological dating and hormone profile, the partici-
pant was withdrawn from the study. A total of 34 women
were sampled, but only 22 were included in the study. 12
women were withdrawn from the study as follows: four
were withdrawn due to a mismatch in dating, five due to
pathological (atrophic or hyperplastic) endometrium and
three due to unsatisfactory samples. The 22 patients were
divided into 5 groups according to the menstrual phase.
There was no significant difference in terms of the
patient's age between the five groups (Table 1).
Table 1: Characteristics and hormonal profile (Mean ± SD) of the study groups.
Menstrual Phase
(days)
Early proliferative
(5-7)
Mid proliferative
(8-11)
Late proliferative
(12-14)
Early
Secretory
(15-18)
Mid
Secretory
(19-23)
No. cases 4 4 4 4 6
Age 43.6 ± 0.5 37.5 ± 8.81 41 ± 3.55 41.2 ± 6.8 42.1 ± 4.63
LH (IU/L) 3.66 ± 0.9 6.35 ± 2.15 20.12 ± 21.6 29.25 ± 43.68 2.94 ± 1.92
FSH (IU/L) 5.38 ± 2.33 5.83 ± 3.0 7.1 ± 3.57 6.54 ± 4.62 5.07 ± 7.44
Progesterone
(ng/mL)
0.36 ± 0.28 0.42 ± 0.26 0.61 ± 0.55 1.42 ± 0.78 7.57 ± 4.42
E2 (pg/ml) 64.5 ± 25.11 150.5 ± 73.5 179.77 ± 39.1 197.52 ± 156.94 117.67 ± 107.53Reproductive Biology and Endocrinology 2009, 7:152 http://www.rbej.com/content/7/1/152
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The local ethics committee and the National Committee
for Human Medical Research granted ethical approval for
the study (2830404) and all patients gave informed con-
sent.
Sample collection
All specimens were collected in aseptic conditions in the
operating theatre.
Endometrial samples from the uterus were taken by open-
ing the uterine cavity and peeling the inner layer. Due to
their small size, fallopian tube samples were taken com-
plete. Endometrial samples from women undergoing adn-
exal surgery were taken using a pipelle curette.
Samples were collected at room temperature and trans-
ported to the laboratory where they were immediately fro-
zen and kept at -80°C in until used.
RNA extraction
Total RNA from endometrial and fallopian tube tissues
was extracted using a total RNA isolation kit EZ-RNA (Kib-
butz Bet HaEmek, Israel) according to manufacturer's
instructions.
RNA concentration was determined spectrophotometri-
cally. First strand cDNA synthesis for RT-PCR: To obtain
the cDNA, RNA (5 μg) was denatured at 70°C for 10 min
and then reverse transcribed in the presence of 25 ng/μl
random primer (Promega, Mannheim, Germany), 2.5
mM MgCl2, 0.5 mM deoxy-NTPs, 10 mM dithiothreitol,
and 10 U ribonuclease H- reverse transcriptase (Super-
Script II RT, Life Technologies, Inc Invitrogen, Dorset,
UK.) for 60 min at 42°C, and 5 min at 95°C. Subse-
quently, 10 μl of the resulting cDNA was used as a tem-
plate for PCR.
Reverse transcription-polymerase chain reaction (RT-
PCR)
The 1st strand cDNA product, 10 μl, was subsequently
amplified in a total volume of 50 μl, containing 1.5 U Taq
DNA polymerase (Sigma, St. Louis, MO, USA), 200 μM
dNTPs (Promega, Mannheim, Germany), 2 mM MgCl2,
50 pmol of each primer and buffer (10 mM Tris-HCl, 50
mM KCl, 0.1% Triton x-100). Primers for Glycodelin,
MMP7, Plexin B1 and GAPDH were used. The PCR ampli-
fication for all sets of primers was performed for 30 cycles
in an automated thermocycler profile. Before starting,
each primer was normalized for sub-saturation condi-
tions. We used a series of dilutions of a bulk RNA prepa-
ration to determine sub-saturation conditions for the PCR
products using GAPDH. The amplification parameters
were denatured at 94°C for 5 minutes, followed by 30
cycles as follows: denaturation at 94°C for 30 seconds,
annealing at 58°C for 1 minute and elongation at 72°C
for 90 seconds and at the end of program 72°C extension
for 10 minutes. RT-PCR products were analyzed by 2.5%
agarose ethidium bromide gel electrophoresis. Images
were captured with Polaroid film (Hertfordshire, UK)
under UV light. Products were quantified using a Densit-
ometer system endowed with TINA software (Raytest,
Staubenhardt, Germany). Amplification of the house-
keeping gene GAPDH transcripts was performed simulta-
neously to confirm RNA integrity, efficiency and for
quantification of cDNA. Negative control reactions con-
taining samples without cDNA or Taq enzyme were used.
Primer design
The sequences of appropriate primers were obtained from
the gene bank and prepared at IDT Inc., Hy-Labs,
Rehovot, Israel.
Reverse transcription-polymerase chain reaction (RT-
RCR) for: Glycodelin (gene bank access no.
NM_001018049)
FWD 5'-AAGTTGGCAGGGACCTGGCACTC-3'; Glycode-
lin REV 5'-ACGGCACGGCTCTTCCATCTGTT-3' (420 bp
product).
MMP7 (gene bank access no. NM_002423)
FWD 5'-AAACTCCCGCGTCATAGAAAT-3';
MMP7 REV 5'-TCCCTAGACTGCTACCATCCG-3' (394 bp
product);
Plexin B1 (gene bank access no. F09621) Plexin B1 FWD
5'-GCAGTGTGTTATCCTTTAATGAAA-3' Plexin B1 REV 5'-
CCACTACAAACTGACCCCTC-3'. (150 bp product). For
normalization we used the levels of the housekeeping
gene GAPDH (gene bank access no. M33197).
GAPDH (FWD 5'-TGATGACATCAAGAAGGTGGTGAAG-
3'; REV 5'-TCCTTGGAGGCCATGTGGGCCAT-3' (240 bp
product).
Statistical analysis
Results are expressed as mean ± SEM of 4-6 independent
experiments for each group. Statistical analysis was per-
formed using the SPSS statistical software. Due to the
small sample size in each group, analysis was done using
a nonparametric test: Cruskal-Wallis for each individual
parameter. P < 0.05 was considered statistically signifi-
cant.Reproductive Biology and Endocrinology 2009, 7:152 http://www.rbej.com/content/7/1/152
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Results
Glycodelin expression during the menstrual cycle in the 
human endometrium and fallopian tube
A total of 22 endometrial and fallopian tube biopsies were
analyzed for Glycodelin expression. Semi-quantitative RT-
PCR was performed to examine Glycodelin mRNA relative
expression (Table 2, Figure 1). The 420-bp product corre-
sponding to Glycodelin and a 240-bp product for glycer-
aldehyde-3-phosphate dehydrogenase (GAPDH) as an
internal control were detected. To compare Glycodelin
mRNA relative expression levels between periods, we ana-
lyzed the ratio of each independent experiment between
the expression level of both Glycodelin and GAPDH from
the same tissue. Figure 1 is a summary of Glycodelin
expression through various periods during menstrual
cycle. In the endometrium, glycodelin expression declines
sharply on days 12-14 as compared with days 5-7 (0.072
± 0.15 versus 0.734 ± 0.16 Glycodelin/GAPDH ratio, P <
0.05). Glycodelin expression was found to be significantly
higher in days 19 - 23 compared to the level in days 12-14
(0.819 ± 0.564 versus 0.072 ± 0.343, P < 0.05). Similar
results were observed in the fallopian tube.
MMP7 expression during the menstrual cycle in the human 
endometrium and fallopian tube
A total of 22 endometrial and fallopian tube biopsies were
analyzed for MMP7 expression (Table 2, Figure 2). Semi-
quantitative RT-PCR was performed to examine MMP7
mRNA relative expression. The 394-bp product corre-
sponding to MMP7 and a 240-bp product for glyceralde-
hyde-3-phosphate dehydrogenase (GAPDH) as an
internal control were detected. To compare MMP7 mRNA
relative expression levels between periods, we analyzed
the ratio of each independent experiment between the
expression level of either MMP7 and GAPDH from the
same tissue. Figure 2 summarizes MMP7 expression
through the various periods during the menstrual cycle.
Although the level of MMP7 secretion was the highest in
the secretory phase, the difference from the proliferative
phase did not reach statistical significance, neither in the
endometrium nor in the fallopian tube. This could result
from a lack of power.
Plexin B1 expression during the menstrual cycle, in the 
human endometrium and in the fallopian tube
A total of 22 endometrial and fallopian tube biopsies were
analyzed for plexin B1 expression (Table 2, Figure 3).
Semi-quantitative RT-PCR was performed to examine
Plexin B1 mRNA relative expression. The 150-bp product
corresponding to Plexin B1 and a 240-bp product for glyc-
eraldehyde-3-phosphate dehydrogenase (GAPDH) as an
internal control were detected. To compare Plexin B1
mRNA relative expression levels between periods, we ana-
lyzed the ratio of each independent experiment between
the expression level of either Plexin B1 and GAPDH from
the same tissue. Figure 3 summarizes Plexin B1 expression
through various periods during the menstrual cycle.
Plexin B1 expression in the endometrium during days 19
- 23 was significantly higher compared to days 12 - 14
(1.166 ± 0.42 versus 0.523 ± 0.299, P < 0.005). In the Fal-
lopian tube Plexin B1 level did not change significantly
through the menstrual cycle.
Discussion
The ability of uterine epithelium to allow the trophoblast
to adhere depends on the acquisition of a specific func-
tional state referred to as receptivity [1-5]. Epithelial cells
have an apical plasma membrane that is normally repel-
lent and does not allow opposing uterine or embryonic
cells such as trophoblast to adhere. At the time of implan-
Table 2: Expression values of PLB1, MMP 7 and Glycodelin (Mean ± SD) in the endometrium (E) and in the fallopian tube epithelium 
(F).
Menstrual Phase
(days)
*Early proliferative
(5-7)
*Mid proliferative
(8-11)
Late proliferative
(12-14)
*Early Secretory
(15-18)
*Mid Secretory
(19-23)
PLB1 E 0.709 ± 0.215
P = 0.406
0.892 ± 0.461
P = 0.227
0.523 ± 0.299 0.881 ± 0.664
P = 0.135
1.166 ± 0.427
P = 0.002
PLB1 F 0.446 ± 0.261
P = 0.473
0.822 ± 0.482
P = 0.419
0.580 ± 0.279 0.703 ± 0.241
P = 0.529
0.741 ± 0.127
P = 0.093
MMP 7 E 0.285 ± 0.232
P = 0.722
0.629 ± 0.684
P = 0.525
0.346 ± 0.200 0.837 ± 0.627
P = 0.186
0.698 ± 0.402
P = 0.14
MMP 7 F 0.302 ± 0.381
P = 0.635
0.338 ± 0.423
P = 0.692
0.207 ± 0.213 0.298 ± 0.286
P = 0.631
0.611 ± 0.458
P = 0.115
Glycodelin E 0.742 ± 0.157
P = 0.04
0.791 ± 0.508
P = 0.227
0.072 ± 0.343 0.747 ± 0.502
P = 0.003
0.819 ± 0.564
P = 0.01
Glycodelin F 0.235 ± 0.269
0.739
0.612 ± 0.338
P = 0.692
0.329 ± 0.398 0.376 ± 0.492
P = 0.88
0.796 ± 0.196
P = 0.002
* Versus days 12-14Reproductive Biology and Endocrinology 2009, 7:152 http://www.rbej.com/content/7/1/152
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tation, however, uterine epithelial cells are reprogrammed
towards adhesiveness for trophoblast [1-5]. It has been
proposed that this process may be under the control of
master genes, which regulate the expression of the polar-
ized epithelial phenotype and can prepare the apical cell
pole of uterine cells contact with the trophoblast [18].
In this study women with an age ranging from 30 to 50
years with regular menstrual cycle were selected. It is well
accepted that age is a major fertility rate limiting factor in
terms of the ovary and folliculogenesis. However, from
the oocyte donation model, it seems that the recipient's
age does not play a substantial role in the success of
oocyte donation, implying that endometrial receptivity is
unaltered by age [19,20].
In agreement with previous studies, both glycodelin [12]
and MMP7 [21] genes were expressed in the endometrium
and in the fallopian tube. Glycodelin in the fully glyco-
sylated form, a 28-kD glycoprotein, is the predominant
protein product of secretory-phase endometrial epithelial
cells [12]. Previously it has been referred to as placental
protein 14 [12], pregnancy-associated endometrial 2
globulin [12], and progestagen-associated endometrial
protein [12]. Although primarily produced in the uterus,
this protein has also been detected in follicular and semi-
nal fluids, in cultured hematopoietic precursor cells, and
Glycodelin expression in primary endometrial versus fallopian tube biopsies Figure 1
Glycodelin expression in primary endometrial versus fallopian tube biopsies. Line-graph representing mean ± SEM 
of total Glycodelin to GAPDH ratio from 22 endometrial and 22 fallopian tube biopsies, taken from different menstrual cycle 
days. Blue line-graph represents primary endometrial biopsies, Pink line-graph represents fallopian tube biopsies, * = P < 0.05 in 
both tissues between days 19-23 compared to days12-14.Reproductive Biology and Endocrinology 2009, 7:152 http://www.rbej.com/content/7/1/152
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in breast carcinoma. Matrix metalloproteinase-7 (MMP7,
matrilysin or uterine metalloproteinase) degrades casein,
fibronectin and gelatin types I, III, IV and V [21]. In a pre-
vious study, MMP7 has been shown to be expressed dur-
ing the receptive phase localized to endometrial glandular
and luminal epithelium with low transcript levels found
in infertile patients [21]. In the present study, the levels of
MMP7 during the secretory phase were higher than in the
proliferative phase, however this change was not statisti-
cally significant and may result from a lack of statistical
power.
All three genes were also expressed in the fallopian tube.
Given that the fallopian tubes and the uterus are both
from the same Müllerian-tract origin, it is not surprising
that similar genes are present in both the uterus and the
fallopian tubes. Still, the similar pattern of expression
should expose the embryo to undesirable ectopic implan-
tation. The fact that this is not usually the case suggests
that ectopic implantation is not a passive randomized
event but requires certain pathology in the fallopian tube
or in the embryo or in both.
In the present study plexin B1 expression was found in
human endometrial tissue and its level was found to be
significantly higher at the period corresponding with the
implantation window. The involvement of the Plexin-
Semaphorin system in the reproductive system has been
scarcely investigated. Plexin B1 expression was found in
the mouse ovary, suggesting a possible role for the recep-
MMP7 expression in primary endometrial versus fallopian tube biopsies Figure 2
MMP7 expression in primary endometrial versus fallopian tube biopsies. Line-graph representing mean ± SEM of 
total MMP7 to GAPDH ratio from 22 endometrial and 22 fallopian tube biopsies, taken from different menstrual cycle days. 
Blue line-graph represents primary endometrial biopsies, Pink line-graph represents fallopian tube biopsies.Reproductive Biology and Endocrinology 2009, 7:152 http://www.rbej.com/content/7/1/152
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tor in follicular growth and development [16]. Plexin A1,
as well as semaphorin 3A, was found in the human pla-
centa and uterus [22]. Plexin B1 was also found in a
human endometrial cell line and was suggested to have a
role in endometrial receptivity [17]. To the best of our
knowledge, this is the first report showing the expression
of Plexin B1 in human endometrial tissue. The signifi-
cantly higher expression level on days 19-23 might sug-
gest that plexin B1 is under hormonal regulation.
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